首页|黄芪下瘀血汤合方对四氯化碳诱导肝纤维化小鼠的干预作用及机制

黄芪下瘀血汤合方对四氯化碳诱导肝纤维化小鼠的干预作用及机制

扫码查看
目的 基于NOD样受体热蛋白结构域相关蛋白3(NLRP3)/含半胱氨酸的天冬氨酸蛋白水解酶-1(Caspase-1)/白细胞介素-1β(IL-1β)通路探讨黄芪汤和下瘀血汤合方(黄芪下瘀血汤)对四氯化碳诱导肝纤维化小鼠的干预作用及其可能机制.方法 取6 周龄C57BL/6 小鼠75 只,随机选择15 只作为正常组,其余小鼠腹腔注射15%四氯化碳橄榄油溶液(2 mL/kg体重,每周3 次)造模.1 周后,将造模小鼠随机分为模型组、黄芪汤组、下瘀血汤组和黄芪下瘀血汤组,每组15 只.各用药组继续予四氯化碳造模的同时,每天给予相应药物进行灌胃,正常组和模型组灌胃等剂量双蒸水,连续灌胃5 周.6 周末处死各组小鼠,检测血清丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)水平,HE染色和天狼猩红染色观察肝组织炎症和胶原沉积情况,试剂盒检测肝组织中超氧化物歧化酶(SOD)、丙二醛(MDA)、羟脯氨酸(Hyp)含量,Western blot法检测肝组织中胶原增生标志物层连蛋白(FN)、I型胶原(Col I)、α-平滑肌肌动蛋白(α-SMA)以及NLRP3、Caspase-1、IL-1β蛋白表达情况.结果 黄芪汤、下瘀血汤、黄芪下瘀血汤均可明显降低肝纤维化模型小鼠肝功能和血清炎性细胞因子水平,上调肝组织SOD活性,降低MDA、Hyp含量,改善肝组织炎性损伤和胶原沉积,下调肝组织FN、Col I和α-SMA蛋白表达水平,且黄芪下瘀血汤较单用黄芪汤和下瘀血汤组有进一步增强的作用,尤其以肝组织胶原沉积和Hyp更为显著,差异均有统计学意义(P均<0.05).黄芪下瘀血汤可下调肝组织NLRP3、Caspase-1 和IL-1β蛋白表达水平.结论 黄芪下瘀血汤可有效改善四氯化碳诱导的肝纤维化小鼠的肝功能,减轻肝组织炎症,减少胶原纤维沉积,且防治肝纤维化的作用强于黄芪汤和下瘀血汤,其机制可能与调控NLRP3/Caspase-1/IL-1β通路、抑制炎症及氧化应激反应有关.
Intervention effect and mechanism of Huangqi Xiayuxue Decoction on hepatic fibrosis induced by carbon tetrachloride in mice
Objective It is to investigate the intervention effect and potential mechanisms of the combined decoction of Huangqi Decoction and Xiayuxue Decoction(Huangqi Xiayuxue Decoction)on carbon tetrachloride-induced hepatic fibrosis in mice based on NOD-like receptor pyrin domain containing 3(NLRP3)/Caspase-1/interleukin-1(IL-1β)pathway.Methods Seventy-five 6-week-old C57BL/6 mice were selected,in which15 mice were randomly selected as normal group,and the remaining mice were injected intraperitoneally with 15%CCl4 olive oil solution(2 mL/kg body weight,3 times per week)to establish the models.One week later,the modeled mice were randomly subdivided into model group,Huangqi Decoction group,Xiayuxue Decoction group,and Huangqi Xiayuxue Decoction group,with 15 mice in each group.While continuing CCl4 modeling,the treatment groups were administered the corresponding drugs daily by gavage,and the control and model groups were given an equivalent volume of double-distilled water by gavage,all treated for 5 weeks.At the end of 6 weeks,the mice were euthanized,the serum levels of alanine aminotransferase(ALT),aspartate aminotransferase(AST),tumor necrosis factor-α(TNF-α)and interleukin 6(IL-6)were detected,the liver tissue inflammation and colla-gen deposition were observed by HE staining and Sirius Red staining,the contents of superoxide dismutase(SOD),malon-dialdehyde(MDA)and hydroxyproline(Hyp)in liver tissues were detected by assay kits,the protein expressions of liver tissue collagen proliferation markers such as fibronectin(FN),type Ⅰ collagen(Col I),alpha-smooth muscle actin(α-SMA),and NLRP3,Caspase-1 and IL-1β were detected by Western blot method.Results Huangqi Decoction,Xiayuxue Decoction and Huangqi Xiayuxue Decoction could all significantly reduce indexes of liver function and serum levels of in-flammatory cytokines in model mice with hepatic fibrosis,they also could increase the activity of SOD and decrease contents of MDA and Hyp in liver tissue,improve liver tissue inflammatory injury and collagen deposition,and downregulate the ex-pressions of FN,Col I,and α-SMA in liver tissue,the effects were further enhanced by Huangqi Xiayuxue Decoction com-pared with Huangqi Decoction or Xiayuxue Decoction used alone,particularly in terms of collagen deposition and Hyp in liver tissue,the differences were all statistically significant(all P<0.05).Huangqi Xiayuxue Decoction could also down-regulate the protein expression levels of NLRP3,Caspase-1,and IL-1β in liver tissue.Conclusion Huangqi Xiayuxue De-coction can effectively improve liver function of mice with CCl4-induced hepatic fibrosis,and could alleviate liver tissue in-flammation and reduce collagen deposition,and its preventive and therapeutic effects on hepatic fibrosis were more signifi-cant that those of Huangqi Decoction and Xiayuxue Decoction.Its mechanism is related to regulating NLRP3/Caspase-1/IL-1β pathway to inhibit inflammatory responses and oxidative stress.

hepatic fibrosisHuangqi Xiayuxue DecoctionNLRP3/Caspase-1/IL-1β pathway

平键、金晋、孙磊、成扬

展开 >

上海中医药大学附属曙光医院,上海 201203

肝肾疾病病证教育部重点实验室(上海中医药大学),上海 201203

上海市中医临床重点实验室,上海 201203

复旦大学发育生物学研究所,上海 200438

上海中医药大学肝病研究所,上海 201203

展开 >

肝纤维化 黄芪下瘀血汤 NOD样受体热蛋白结构域相关蛋白3/含半胱氨酸的天冬氨酸蛋白水解酶-1/白细胞介素-1β通路

国家自然科学基金面上项目

81774098

2024

现代中西医结合杂志
中国中西医结合学会河北分会,中华中医药学会

现代中西医结合杂志

CSTPCD
影响因子:1.775
ISSN:1008-8849
年,卷(期):2024.33(7)
  • 17